Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(1.03) per share which beat the analyst consensus estimate o...
Nuwellis shares are trading higher Monday after the company announced Friday that the first pediatric patient has been treated ...
QUELIMMUNE, Manufactured For SeaStar Medical And Licensed By Nuwellis, Targets Pediatric AKI Patients With Sepsis Requiring Kid...
SeaStar Medical Holding Corporation (NASDAQ:ICU) (SeaStar Medical) reports treatment of the first patient in a commercial setti...
Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid...
Reimbursement expected to accelerate medical site activations and cover a portion of the Company's NEUTRALIZE-AKI trial cos...
